hepatitis B

Prophylactic vaccination against hepatitis D virus superinfection: from fiction to reality?
Julia Lang-Meli, Christoph Neumann-Haefelin

Gut Jun 2023, 72 (6) 1030-1032; DOI: 10.1136/gutjnl-2022-328381
Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
Rani Burm, Panagiota Maravelia, Gustaf Ahlen, Sandra Ciesek, Noelia Caro Perez, Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sällberg, Philip Meuleman

Gut Jun 2023, 72 (6) 1186-1195; DOI: 10.1136/gutjnl-2022-327216
Three double-dose reinforced hepatitis B revaccination scheme for patients with cirrhosis unresponsive to the standard regimen: an open-label randomised clinical trial
Álvaro Giráldez-Gallego, Elisa del Pilar Rodríguez-Seguel, Raquel Valencia-Martín, Áurea Morillo-García, Celia Salamanca-Rivera, Ricardo Ruiz-Pérez, María Cuaresma-Duque, Clara Rosso-Fernández, María Teresa Ferrer-Ríos, José Manuel Sousa-Martín, Juan Manuel Praena-Fernández, Trinidad Desongles-Corrales, Aitana Rodríguez-Pérez, Francisco Camino-Durán, Antonia Gasch-Illescas, Javier Ampuero-Herrojo, Juan Manuel Pascasio-Acevedo

Gut Mar 2023, gutjnl-2022-328222; DOI: 10.1136/gutjnl-2022-328222
Quantification of the hepatitis B virus cccDNA: evidence-based guidelines for monitoring the key obstacle of HBV cure
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, Bingqian Qu, Marc Lütgehetmann, Haitao Guo, Stephan Urban, Simon P Fletcher, Ulrike Protzer, Massimo Levrero, Fabien Zoulim, Maura Dandri

Gut May 2023, 72 (5) 972-983; DOI: 10.1136/gutjnl-2022-328380
Quest for immunological biomarkers in the management of CHB patients
Antonio Bertoletti, Nina Le Bert

Gut Mar 2023, gutjnl-2023-329437; DOI: 10.1136/gutjnl-2023-329437
Cracking the host functional network involved in hepatitis B virus cccDNA biology
Barbara Testoni, Alexander Ploss

Gut Jan 2023, gutjnl-2022-329185; DOI: 10.1136/gutjnl-2022-329185
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection
Harry L A Janssen, Jinlin Hou, Tarik Asselah, Henry L Y Chan, Fabien Zoulim, Yasuhito Tanaka, Ewa Janczewska, Ronald G Nahass, Stefan Bourgeois, Maria Buti, Pietro Lampertico, Oliver Lenz, Thierry Verbinnen, Joris Vandenbossche, Willem Talloen, Ronald Kalmeijer, Maria Beumont, Michael Biermer, Umesh Shukla

Gut Jan 2023, gutjnl-2022-328041; DOI: 10.1136/gutjnl-2022-328041
Engineered IFN-α and anti-PDL1 containing compounds to target the liver and restore antiviral protection for HBV cure
Paola Fisicaro

Gut Dec 2022, gutjnl-2022-328902; DOI: 10.1136/gutjnl-2022-328902
Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target
Eloi R Verrier, Gaëtan Ligat, Laura Heydmann, Katharina Doernbrack, Julija Miller, Anne Maglott-Roth, Frank Jühling, Houssein El Saghire, Margaux J Heuschkel, Naoto Fujiwara, Sen-Yung Hsieh, Yujin Hoshida, David E Root, Emanuele Felli, Patrick Pessaux, Atish Mukherji, Laurent Mailly, Catherine Schuster, Laurent Brino, Michael Nassal, Thomas F. Baumert

Gut Dec 2022, gutjnl-2020-323665; DOI: 10.1136/gutjnl-2020-323665
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients
Chao Zhang, Jiesheng Li, Yongqian Cheng, Fanping Meng, Jin-Wen Song, Xing Fan, Hongtao Fan, Jing Li, Yu-Long Fu, Ming-Ju Zhou, Wei Hu, Si-Yu Wang, Yuan-Jie Fu, Ji-Yuan Zhang, Ruo-Nan Xu, Ming Shi, Xueda Hu, Zemin Zhang, Xianwen Ren, Fu-Sheng Wang

Gut Jan 2023, 72 (1) 153-167; DOI: 10.1136/gutjnl-2021-325915

Main menu

hepatitis B

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hepatitis B

Pages